Epigral

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE071N01016
  • NSEID: EPIGRAL
  • BSEID: 543332
INR
1,237.40
-13.7 (-1.1%)
BSENSE

May 25

BSE+NSE Vol: 12.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Net Sales
2,527.18
2,550.13
1,929.19
2,188.40
1,550.94
828.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,527.18
2,550.13
1,929.19
2,188.40
1,550.94
828.60
Raw Material Cost
1,490.66
1,322.40
1,071.60
1,211.76
759.41
386.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.42
(Increase) / Decrease In Stocks
-60.94
31.09
-10.78
-96.97
1.68
-1.20
Employee Cost
129.66
114.48
89.65
86.60
76.79
53.61
Power Cost
156.40
130.08
105.75
122.90
73.53
0.00
Manufacturing Expenses
0.00
0.00
0.00
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
244.33
241.36
191.77
175.18
130.04
128.35
Total Expenditure (Excl Depreciation)
1,960.11
1,839.41
1,447.99
1,499.46
1,041.45
567.28
Operating Profit (PBDIT) excl Other Income
567.07
710.72
481.20
688.94
509.49
261.32
Other Income
14.98
15.21
6.57
7.98
4.11
2.19
Operating Profit (PBDIT)
582.05
725.93
487.77
696.92
513.60
263.51
Interest
71.96
53.27
73.49
65.50
44.27
29.11
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
510.09
672.66
414.28
631.42
469.33
234.40
Depreciation
168.29
132.56
123.56
108.95
85.91
73.54
Profit Before Tax
341.80
540.10
290.72
522.48
383.42
160.86
Tax
8.79
183.40
94.88
169.17
130.64
60.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
333.01
356.70
195.84
353.31
252.79
100.84
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
333.01
356.70
195.84
353.31
252.79
100.84
Share in Profit of Associates
-1.04
0.99
0.03
-0.02
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
331.97
357.69
195.87
353.29
252.79
100.84
Equity Capital
43.14
43.14
41.55
41.55
41.55
41.55
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
2,178.29
1,861.39
1,212.55
1,027.55
684.42
431.66
Earnings per share (EPS)
76.95
82.91
47.14
85.03
60.84
24.27
Diluted Earnings per share
76.95
84.68
47.13
85.03
60.84
17.26
Operating Profit Margin (Excl OI)
22.44%
27.87%
24.94%
31.48%
32.85%
31.54%
Gross Profit Margin
20.18%
26.38%
21.47%
28.85%
30.26%
28.29%
PAT Margin
13.14%
14.03%
10.15%
16.14%
16.3%
12.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -0.90% vs 32.19% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -7.19% vs 82.62% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -20.21% vs 47.70% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 35.09% vs -27.51% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Epigral With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,527.18
1,424.98
1,102.20
77.35%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,527.18
1,424.98
1,102.20
77.35%
Raw Material Cost
1,490.66
811.15
679.51
83.77%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-60.94
-15.16
-45.78
-301.98%
Employee Cost
129.66
84.11
45.55
54.16%
Power Cost
156.40
0.00
156.40
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
244.33
279.45
-35.12
-12.57%
Total Expenditure (Excl Depreciation)
1,960.11
1,159.55
800.56
69.04%
Operating Profit (PBDIT) excl Other Income
567.07
265.43
301.64
113.64%
Other Income
14.98
28.81
-13.83
-48.00%
Operating Profit (PBDIT)
582.05
294.24
287.81
97.81%
Interest
71.96
5.37
66.59
1,240.04%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
510.09
288.87
221.22
76.58%
Depreciation
168.29
56.38
111.91
198.49%
Profit Before Tax
341.80
232.49
109.31
47.02%
Tax
8.79
63.33
-54.54
-86.12%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
333.01
169.16
163.85
96.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
333.01
169.16
163.85
96.86%
Share in Profit of Associates
-1.04
0.00
-1.04
Minority Interest
0.00
-1.96
1.96
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
331.97
167.20
164.77
98.55%
Equity Capital
43.14
6.48
36.66
565.74%
Face Value
10.00
2.00
0.00
Reserves
2,178.29
1,969.98
208.31
10.57%
Earnings per share (EPS)
76.95
51.60
25.35
49.13%
Diluted Earnings per share
76.95
51.60
25.35
49.13%
Operating Profit Margin (Excl OI)
22.44%
18.63%
0.00
3.81%
Gross Profit Margin
20.18%
20.27%
0.00
-0.09%
PAT Margin
13.14%
11.87%
0.00
1.27%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,527.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.90% vs 32.19% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 331.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.19% vs 82.62% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 567.07 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -20.21% vs 47.70% in Mar 2025

Annual - Interest
Interest 71.96 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 35.09% vs -27.51% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.44%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025